Quick Answer
Relay Therapeutics, Inc. reported Shares Outstanding of 173.87 million shares for fiscal year 2025.
Relay Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 173.87M | +3.6% |
| 2024 | 167.76M | +31.6% |
| 2023 | 127.46M | +5.2% |
| 2022 | 121.11M | +11.9% |
| 2021 | 108.21M | +20.4% |
| 2020 | 89.91M | +2126.8% |
| 2019 | 4.04M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 172.63M | +3.4% | +0.5% |
| June 30, 2025 | 171.69M | +28.8% | +0.7% |
| March 31, 2025 | 170.48M | +28.9% | +1.6% |
| December 31, 2024 | 167.76M | +31.6% | +0.5% |
| September 30, 2024 | 166.89M | +35.5% | +25.2% |
| June 30, 2024 | 133.32M | +9.3% | +0.8% |
| March 31, 2024 | 132.30M | +8.9% | +3.8% |
| December 31, 2023 | 127.46M | +5.2% | +3.5% |
- Relay Therapeutics, Inc. showed an increase of +3.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Relay Therapeutics, Inc.’s shares outstanding has grown by 4206.4% (from 4.04 million shares to 173.87 million shares).
- The most recent figure is from Relay Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: